Clinical Trials Logo
  1. Home
  2. Lung Injury
  3. NCT04848272

Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury

Lung Injury Clinical Trial

Official title:
Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury

Clinical Trial Summary

Phase 1 study investigating safety of lanadelumab administration to patients with lung injury

Clinical Trial Description

This study will investigate the safety of inhibition of plasma kallikrein by lanadelumab administration in patients with lung injury. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04848272
Study type Interventional
Source St Vincent's Institute of Medical Research
Contact
Status Active, not recruiting
Phase Phase 1
Start date August 9, 2021
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05054270 - Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients
Not yet recruiting NCT04470297 - Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19 Phase 2
Not yet recruiting NCT01184313 - Acute Lung Injury After Aortic Valve Surgery N/A
Not yet recruiting NCT06296173 - Open Lung Protective Extubation Following General Anesthesia N/A
Not yet recruiting NCT06446544 - Functional Residual Capacity and Alveolar Recruitment in Single-lung Ventilation: a Randomized Study N/A
Not yet recruiting NCT03661502 - Effect of Variable Volume Ventilation on Lung Compliance N/A
Recruiting NCT04296071 - Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Completed NCT04645316 - The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung N/A
Recruiting NCT02299921 - Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
Recruiting NCT05559970 - Inhalational Sedation and Mechanical Power N/A
Completed NCT03581006 - Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial
Recruiting NCT05228717 - Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19
Recruiting NCT04372953 - Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial). N/A
Not yet recruiting NCT05363085 - The Cerebral-Respiratory Interaction in Controlled Mechanically Ventilated Neurosurgical Patients. (The CeRes-CMV Study)
Recruiting NCT02444858 - Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury Phase 1/Phase 2
Completed NCT03924206 - Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit
Recruiting NCT06416709 - Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases Phase 1/Phase 2
Withdrawn NCT01939067 - Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP Phase 1
Recruiting NCT05401474 - Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW) N/A
Completed NCT03437499 - Adrenomedullin Changes After Sustained Inflation or Positive Pressure Ventilation at Birth N/A